Scandinavian ChemoTech - Improved sales
2023-08-16 07:40:00
Redeye leaves its comments on Scandinavian ChemoTech following the company’s Q2 2023 report. The report contained stronger sales and higher OPEX than expected.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/